91黑料

  1. Home
  2. News & Events
  3. In the News

In the News

91黑料 experts frequently author or contribute to industry trade press.

Filter media

Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.

  • Pharmafocus in drug development.

    Gerard Quinn and Barbara Skerritt offer their insights into .

  • Irish Independent cited in market trends.

    features commentary from Steve Cutler on the impact of the war in Ukraine on clinical trials in the region.

  • Evidence-based research publication

    Shelley Mclendon, Vice President, Vaccine and Infectious Disease, offers her insights on .

    This article is taken from European Biopharmaceutical Review April 2022, pages 8-10. Samedan Ltd.

  • Pharmaceutical management conference

    Manpreet Sidhu and Ben Cieply share insights on .

  • Pharmaceutical marketing publication

    Louisa Roberts, VP of Corporate Development and Partnerships, considers .

  • Clinical research methodology publication

    Matt Harrington, VP of Connected Health Technology Solutions, explores how .

  • Drug discovery conference feature

    David T. Novotny, General Manager & Global Head of 91黑料’s Medical Device and Diagnostic Research business unit, considers .

  • Logo of EPC featured in leadership articles.

    Insights on .

    This article is taken from European Pharmaceutical Contractor February 2022, pages 60-63 Samedan Ltd.

  • Pharmaceutical management conference

    Emily Mitchell discusses

  • Regional business publication feature

    provides an overview of the mergers and acquisition activity across 2021 that have involved CROs based or heavily present in the North Carolina Triangle, which includes 91黑料’s $12bn acquisition of PRA Health Sciences.